Eye drop study for droopy eyelids in adults
Part of Eyes & vision clinical trials.
This study tests a new eye drop (oxymetazoline) to see if it can help lift droopy eyelids in adults. To join, you must have a certain amount of eyelid droop and some vision loss in your upper field of view, and you should feel that the droop bothers you enough to want treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have been diagnosed with acquired droopy eyelid in both eyes (not present since birth).
- In your treated eye, the distance from your upper eyelid edge to your pupil center is between 0 and 2 mm.
- You have some vision loss in the upper part of your field of view in the eye that will be treated.
- You consider the droop bothersome and are willing to receive treatment for it.
- You can self-administer the eye drops or have a caregiver do so, and you are not taking certain prohibited medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment for Chinese patients whose droopy upper eyelid (acquired blepharoptosis) seriously affects their vision. It may help if your eyelid droops low enough to block part of your sight and you haven't had previous corrective surgery or certain eye conditions.
This study compares two eyedrop treatments—Upneeq and Lumify—to see which works better for acquired droopy eyelid (ptosis). It may help you if you have a droopy eyelid that makes it harder to see or affects your appearance.
This study uses high-speed video to measure how the upper eyelid moves in children with droopy eyelids (ptosis). It may help doctors better understand eyelid function and improve treatment options.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
This study tests a new eye drop medicine to see if it is safe and how the body handles it. It is for healthy adults only, not for treating a condition.
This study tests an eye drop to help stabilize the natural tear film on the surface of the eye. It may help people who have normal tear production but could benefit from better tear film stability.
Hear when a new Acquired Blepharophimosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.